Principal Investigator
Lazaros Lekakis
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240912
Clinical Trial Summary
A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, In Participants with Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM) Systemic Sclerosis, Rheumatoid Arthritis (RA) (Breakfree-1)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Transplant/cellular therapy
Contact Information
Phone Number
+1 (954) 8177628